相关实验视频
Updated: Jan 9, 2026

05:18
A Protocol for Constructing a Rat Wound Model of Type 1 Diabetes
Published on: February 17, 2023
5.5K
更新关于脂质和葡萄糖控制对糖尿病伤口愈合的影响
Rui Sun1, Yang Xu1, Zhenjun Ji1
1Department of Cardiology, Zhongda Hospital, Southeast University, Nanjing, China.
Metabolism open
|December 1, 2025
概括
高血糖和脂质失调会通过破坏新陈代谢途径和增加炎症,使慢性糖尿病伤口恶化. 针对性治疗和先进的伤口护理显示出改善愈合结果的希望.
科学领域:
- 内分泌学 在内分泌学.
- 分子生物学分子生物学
- 伤口治愈研究研究 伤口治愈研究
背景情况:
- 慢性糖尿病伤口是糖尿病的一个重要并发症,通常与高血糖和脂质不良有关.
- 代谢失调会影响细胞功能和炎症微环境,阻碍伤口的修复.
研究的目的:
- 审查糖尿病伤口病原性中高血糖和脂质失调的基础分子机制.
- 评估当前和新兴的治疗策略,以管理慢性糖尿病伤口.
主要方法:
- 关于分子机制和治疗干预的综合文献综述.
- 分析关键的代谢途径 (hexosamine生物合成,聚) 和它们在伤口愈合中的作用.
- 对药理学药剂 (甲胺,PPAR激动剂,SGLT2抑制剂,GLP-1受体激动剂) 和先进疗法 (NPWT,HBOT,再生医学) 的评估.
主要成果:
- 高血糖症和脂质失调症通过改变代谢途径,炎症和氧化应激导致糖尿病伤口.
- 新兴疗法在调节伤口微环境和恢复细胞功能方面显示出潜力.
- 结合全身和局部治疗的多模式方法提供了更好的临床结果.
结论:
- 改善葡萄糖和脂质控制对于优化糖尿病伤口愈合至关重要.
- 个性化,多模式的治疗策略,整合药理和先进的伤口护理,对于更好的患者结果至关重要.
相关概念视频
Diabetes: Management and Pharmacotherapy
848
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
848
Diabetes Mellitus: Overview and Type I Subtype
4.8K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
4.8K
Diabetes Mellitus: Type 2 and Gestational
4.3K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
4.3K
Hormones Regulating Blood Glucose
6.3K
Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
In addition to accelerating glucose uptake and utilization, insulin has...
6.3K
Pathophysiology of Diabetes
3.1K
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
3.1K
Hypoglycemia and Glucagon
778
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
778

